Birmingham, West Midlands -- (SBWIRE) -- 12/04/2013 -- Value Penny Stocks issues special report on: Clovis Oncology Inc (NASDAQ:CLVS), Allied Nevada Gold Corp. (NYSEMKT:ANV), Canadian Solar Inc. (NASDAQ:CSIQ), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
Clovis Oncology Inc (NASDAQ:CLVS) was trading lower by -2.66 points or -4.50% to $56.29.So far, around 1.34 million shares have changed hands in this session. After opening at $56.85, the stock hit as high as $58.95. However, it traded between $14.40 and$86.29 over the last twelve months. Clovis Oncology, Inc. (Clovis) is a Development-stage Company. The Company is a Biopharmaceutical Company. The Company focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets.
Has CLVS Found The Bottom and Ready To Move Up? Find Out Here
Allied Nevada Gold Corp. (NYSEMKT:ANV) was at $3.26, showing a 5.84% increase. Around 2.78 million shares have been traded, versus an-average trading volume of 3.81M shares. The company is now valued at around $338.86 million. Allied Nevada Gold Corp. (Allied Nevada) is a gold and silver producer focused on mining, development, and exploration of properties in the state of Nevada.
For How Long ANV Gloss will Attract Investors? Find out via this report
Canadian Solar Inc. (NASDAQ:CSIQ) moved 3.50 per cent higher at $30.49 and is trading between $28.83 and $31.04 after opening the day at $28.85. Its performance over the last five days remained -1.26%, which stands at 6.42% for a month. Going back further than one month, 1-year performance after recent close was 796.76%. Canadian Solar Inc. (CSI) designs, develops, and manufactures solar wafers, cells and solar module products that convert sunlight into electricity for a variety of uses.
Will CSIQ Continue To Move Higher? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares rose today, gaining 6.96 per cent to $4.68. The stock is down around -23.15% in 2013 and -34.08% for the last 12 months. Around 3.07 million shares changed hands so far in this session compared to an-average trading volume of 2.28M shares. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company discovering, developing and preparing to commercialize medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer.
Why Should Investors Buy MACK After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)